Trifan A

5 publications in the catalogue · 2011–2018 · 1 as first author

5 publications

Product

Diseases

Co-authors

  1. Real-world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis.

    Preda CM et al. · Liver Int · 2018

    FibroTest HCV

  2. Non-invasive evaluation of liver fibrosis in chronic hepatitis C.

    Trifan A et al. · Rev Med Chir Soc Med Nat Iasi · 2012

    FibroTest HCV

  3. Performances of Elasto-FibroTest(®), a combination between FibroTest(®) and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C.

    Poynard T et al. · Clin Res Hepatol Gastroenterol · 2012

    Elasto-FibroTest FibroTest HCV

  4. Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard.

    Poynard T et al. · J Hepatol · 2012

    FibroTest HCV

  5. FibroTest and Fibroscan performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate.

    Poynard T et al. · Clin Res Hepatol Gastroenterol · 2011

    FibroTest HCV